This loss of TTP expression appears to be a critical factorin the progression of high-risk HPV-associated cervical cancer, since thepresence of TTP in cervical tumor cells impedes their tumorigenic potentialthrough rapid decay of E6-AP mRNA. This evidence concerns the gene UBE3A and uterine cervix neoplasm.